// App-Quantinova.ai

TCT-48 : Two Year Follow-Up And Sub-group Analysis Of A Polymer-Free Sirolimus- And Probucol-Eluting Stent vs. A New Generation Zotarolimus-Eluting Stent In Coronary Artery Disease

Researchers

Presenter

  • Lamin King

Principal Investigators

  • lamin king

  • Robert Byrne

  • Salvatore Cassese

  • Tomohisa Tada

  • Julinda Mehilli

  • Adnan Kastrati

Medical Centers

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • Deutsches Herzzentrum Munchen, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Coronary Artery Disease

  • Diabetes

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • ZoMaxx

  • Rapacan

  • Probucol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved